These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature. Anwar MA, Murad F, Dawson E, Abd Elmageed ZY, Tsumagari K, Kandil E. J Surg Res; 2016 Jun 15; 203(2):407-15. PubMed ID: 27363650 [Abstract] [Full Text] [Related]
24. Ciliated Muconodular Papillary Tumors of the Lung Can Occur in Western Patients and Show Mutations in BRAF and AKT1. Liu L, Aesif SW, Kipp BR, Voss JS, Daniel S, Aubry MC, Boland JM. Am J Surg Pathol; 2016 Dec 15; 40(12):1631-1636. PubMed ID: 27454941 [Abstract] [Full Text] [Related]
29. [Molecular features of metanephric adenoma and their values in differential diagnosis]. Wang X, Shi SS, Yang WR, Ye SB, Li R, Ma HH, Zhang RS, Lu ZF, Zhou XJ, Rao Q. Zhonghua Bing Li Xue Za Zhi; 2017 Jan 08; 46(1):38-42. PubMed ID: 28072975 [Abstract] [Full Text] [Related]
30. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas. Yoshimoto K, Hatae R, Suzuki SO, Hata N, Kuga D, Akagi Y, Amemiya T, Sangatsuda Y, Mukae N, Mizoguchi M, Iwaki T, Iihara K. Neuropathology; 2018 Feb 08; 38(1):3-10. PubMed ID: 28840946 [Abstract] [Full Text] [Related]
33. Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction. Paja Fano M, Ugalde Olano A, Fuertes Thomas E, Oleaga Alday A. Endocrinol Diabetes Nutr; 2017 Feb 08; 64(2):75-81. PubMed ID: 28440781 [Abstract] [Full Text] [Related]
34. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas. Routhier CA, Mochel MC, Lynch K, Dias-Santagata D, Louis DN, Hoang MP. Hum Pathol; 2013 Nov 08; 44(11):2563-70. PubMed ID: 24071017 [Abstract] [Full Text] [Related]
36. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J. Diagn Pathol; 2016 Jun 27; 11(1):55. PubMed ID: 27350555 [Abstract] [Full Text] [Related]
37. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma. Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ. Diagn Cytopathol; 2015 Oct 27; 43(10):786-90. PubMed ID: 26152656 [Abstract] [Full Text] [Related]
38. Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma. Bullock M, O'Neill C, Chou A, Clarkson A, Dodds T, Toon C, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Learoyd DL, Capper D, von Deimling A, Clifton-Bligh RJ, Gill AJ. Endocr Relat Cancer; 2012 Dec 27; 19(6):779-84. PubMed ID: 22997209 [Abstract] [Full Text] [Related]